Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1b Study of Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma With Biomarker Correlatives

NCT02277197 is registered in ClinicalTrials.gov with James J Lee as lead sponsor.

NCT NCT02277197
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02277197 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1b Study of Ficlatuzumab and Cetuximab in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma With Biomarker Correlatives
Lead sponsor
James J Lee
Phase
Phase 1
Overall status
Completed
Start date
August 31, 2015
Completion date
February 28, 2018
Enrollment
14 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, squamous cell of head and neck, squamous cell carcinoma of the head and neck, squamous cell carcinoma, head and neck